With the New Year nearly upon us, the diagnostic imaging industry will finally begin to realize the effects of Section 502 of the Consolidated Appropriations Act of 2016. For more than a year, the industry has been humming with talk of anticipated reduction of Medicare payments, expected to impact diagnostic imaging facilities still using analog and computed radiography (CR) technologies. As we are well aware, Section 502 of the Consolidated Appropriations Act of 2016 provides that Medicare reimbursements will be reduced by 20 percent per year for providers submitting claims for analog X-ray studies beginning this year. From 2018 through 2022, payments for imaging tests performed on CR equipment will be reduced by 7 percent, with a 10 percent reduction beginning in 2023.

The past decade has witnessed significant developments in ultrasound technologies, ranging from portable devices, wireless transducers to 3-D/4-D ultrasound imaging and artificial intelligence. Researchers and scientists are endeavoring on developing technologies that simplify diagnostic procedures, improve efficiency of clinicians and enhance image quality. These research and development activities focus on improving overall quality of patient care. In addition, manufacturers are placing an emphasis on implementing automation in premium-tier systems, portable devices and point-of-care (POC) solutions. The prime focus of vendors will be on offering cost-effective devices with growing innovation and competition in the global industry. 

For all the benefits of medical imaging, most forms come with the inherent danger of radiation exposure. Public radiation exposure has increased significantly overall in the last 30 years, and according to a 2006 report from the National Council on Radiation Protection and Measurements (NCRP), medical imaging accounted for nearly half (48 percent) of all public exposure that year. Several high-profile cases of excessive radiation exposure due to medical imaging have brought the discussion into the public eye, which in turn has spurred greater focus on radiation safety among healthcare facilities and their various regulatory bodies.

The Mayo Clinic defines radiation therapy as a type of cancer treatment that uses beams of intense energy to kill cancer cells, mostly getting its power from X-rays, but the power can also come from protons or other types of energy. Most often, it is in the form of external beam radiation therapy. In fact, according to the National Cancer Institute, more than half of all people with cancer receive radiation therapy as part of their treatment, making it one of the most common treatments for cancer.